Business Services
Medical
Biotechnology
PRA Health Sciences
$96.979876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$96.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$2.39 (2.53%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell PRAH and other stocks, options, ETFs, and crypto commission-free!
About PRAH
PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutios segment. Read More The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights; and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC.
Employees
16,400
Headquarters
Raleigh, North Carolina
Founded
1976
Market Cap
6.39B
Price-Earnings Ratio
40.90
Dividend Yield
0.00
Average Volume
552.19K
High Today
$97.29
Low Today
$94.79
Open Price
$94.79
Volume
361.21K
52 Week High
$121.98
52 Week Low
$82.12
Collections
Business Services
Medical
Biotechnology
Pharmaceutical
Biopharmaceutical
Technology
Health
2014 IPO
PRAH News
Price Paid on Robinhood
5% Higher
Right Now
52 Week Low
$79.20
Average Price Paid
$92.78
52 Week High
$121.98
Analyst Ratings
50%
of 14 ratings
Buy
50%
Hold
43%
Sell
7%
PRAH Earnings
$0.84
$1.00
$1.15
$1.31
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 30, After Hours